6LJ Intrinsic Valuation and Fundamental Analysis - Matinas BioPharma Holdings Inc

	Matinas BioPharma Holdings Inc F:6LJ	US
	Societatea de Producere a Energiei Electrice in Hidrocentrale Hidroelectrica SA F:E28	RO
B	Bitcoin Group SE DUS:ADE	DE
S	Sonid Inc KOSDAQ:060230	KR
M	Maple Leaf Foods Inc F:M1L	CA
M	Merafe Resources Ltd JSE:MRF	ZA
A	Australian Critical Minerals Ltd ASX:ACM	AU

Intrinsic Value

Is 6LJ undervalued or overvalued?

See the intrinsic value estimate for Matinas BioPharma Holdings Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.

Do our valuations actually work? See backtest results .

6LJ Intrinsic Value

Unlock

Today vs. history

See how today’s valuation compares with 6LJ’s past valuations and how the stock performed after similar periods.

See what happened next Free account required

Track Buy Zone

20% below Intrinsic Value

Get notified when the price drops into your buy zone

Intrinsic Value Locked

Current Price €2.69

Margin of Safety 20% Locked

Or choose another margin of safety

0% below Intrinsic Value

10% below Intrinsic Value

30% below Intrinsic Value

40% below Intrinsic Value

50% below Intrinsic Value

Custom

Fundamental Analysis

What Matinas BioPharma Does

Biotechnology Health Care

Matinas BioPharma Holdings, Inc. is a clinical-stage biopharmaceutical company. The company is headquartered in Bedminster, New Jersey and currently employs 34 full-time employees. The company went IPO on 2014-06-03. The firm is focused on delivering groundbreaking therapies using its lipid nanocrystal (LNC) platform delivery technology (LNC Platform) to maximize global clinical impact and patient access.

Headquarters: United States of America US
Employees: 34
IPO date: Jun 3, 2014